331 Tumor markers associated with increased survival in a phase II trial of dendritic cell/tumor-initiating-cell vaccine AV-GBM-1 in patients with newly diagnosed glioblastoma
oleh: Gabriel Nistor, Robert Dillman, Daniela Bota, David Piccioni, Christopher Duma, Renato LaRocca, Santosh Kesari, Jose Carrillo, Robert Aiken, Frank Hsu, Xiao-Tang Kong, Thomas Taylor, Mehrdad Abedi, Candace Hsieh
| Format: | Article |
|---|---|
| Diterbitkan: | BMJ Publishing Group 2021-11-01 |
Deskripsi
No description available for this item.